Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Rev Mal Respir ; 29(1): 94-7, 2012 Jan.
Artículo en Francés | MEDLINE | ID: mdl-22240228

RESUMEN

INTRODUCTION: Inhaled foreign bodies are commonly reported in childhood but less so among adults. We report the case of a patient who inhaled a medicinal preparation containing meprobamate and quinine sulfate. The consequence of this was caustic damage to the airways. CASE REPORT: A 64-year-old woman came to the emergency room because of dyspnea, oropharyngeal pain and sialorrhea. She reported that she had inhaled a capsule containing meprobamate and quinine sulfate the previous day. Flexible bronchoscopy showed evidence of caustic damage to the larynx and lower airways. The patient was treated by fasting, corticoids and intravenous broad-spectrum antibiotics. All the lesions recovered and she was discharged from the hospital 15 days after the event. CONCLUSIONS: Inhalation of drugs mostly leads to airway obstruction. Risk of harm is influenced by neurological status, the motility of the digestive system and the properties of the drug. To the best of our knowledge, this is the first time that caustic airway disease has been described following inhalation of a medicinal preparation containing meprobamate and quinine. It highlights the need to be familiar with the chemical properties of medications when prescribing them to patients who are at risk of aspiration.


Asunto(s)
Bronquios , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Cuerpos Extraños/diagnóstico , Preparaciones Farmacéuticas/administración & dosificación , Enfermedad Pulmonar Obstructiva Crónica/etiología , Bronquios/efectos de los fármacos , Bronquios/cirugía , Broncoscopía , Femenino , Cuerpos Extraños/complicaciones , Humanos , Meprobamato/administración & dosificación , Meprobamato/efectos adversos , Persona de Mediana Edad , Relajantes Musculares Centrales/administración & dosificación , Relajantes Musculares Centrales/efectos adversos , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/cirugía , Comprimidos Recubiertos
3.
Epidemiology ; 7(2): 131-9, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8834551

RESUMEN

We utilized data from two Kaiser Permanente medical care programs to evaluate risks of hematopoietic and lymphoproliferative (HLP) malignancies after use of 14 common medications. The subjects were adult cases of non-Hodgkin's lymphoma (NHL) (N = 94), multiple myeloma (N = 159), and leukemia (N = 257) and individually matched controls (N = 695). Abstractors reviewed medical records and recorded medication notations. Using a minimum 5-year exposure lag between first notation and malignancy diagnosis, the risk of NHL was greater among plan members who were prescribed amphetamines [odds ratio (OR) = 2.2; 95% confidence interval (CI) = 1.1-4.8], lidocaine (OR = 2.6; 95% CI = 1.2-5.5), and meprobamate (OR = 2.1; 95% CI = 1.03-4.3). The risk of NHL rose with increasing number of medical record notations for amphetamines; however, there was no association with number of notations for lidocaine or meprobamate. The odds ratio for total leukemia was decreased among patients who took chloramphenicol (OR = 0.4; 95% CI = 0.2-0.97).


Asunto(s)
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Leucemia/inducido químicamente , Linfoma no Hodgkin/inducido químicamente , Mieloma Múltiple/inducido químicamente , Adulto , Anciano , Anfetaminas/administración & dosificación , Anfetaminas/efectos adversos , California/epidemiología , Estudios de Casos y Controles , Cloranfenicol/administración & dosificación , Cloranfenicol/efectos adversos , Intervalos de Confianza , Prescripciones de Medicamentos/estadística & datos numéricos , Femenino , Sistemas Prepagos de Salud/estadística & datos numéricos , Humanos , Leucemia/epidemiología , Lidocaína/administración & dosificación , Lidocaína/efectos adversos , Linfoma no Hodgkin/epidemiología , Masculino , Meprobamato/administración & dosificación , Meprobamato/efectos adversos , Persona de Mediana Edad , Mieloma Múltiple/epidemiología , Oportunidad Relativa , Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA